scholarly article | Q13442814 |
P50 | author | Ania K Majewska | Q61162208 |
Brandon K. Harvey | Q64867341 | ||
P2093 | author name string | Yu Zhang | |
Emily A Kelly | |||
Cassandra E Lamantia | |||
Rebecca L Lowery | |||
P2860 | cites work | Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity | Q39686097 |
Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors | Q40238020 | ||
Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain | Q40329324 | ||
Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression | Q40972848 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Remodeling of synaptic structure in sensory cortical areas in vivo. | Q42492164 | ||
Sindbis vector SINrep(nsP2S726): a tool for rapid heterologous expression with attenuated cytotoxicity in neurons | Q44237703 | ||
Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain | Q44686125 | ||
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system | Q45007196 | ||
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain | Q45420843 | ||
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo | Q45709105 | ||
Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors | Q45756988 | ||
Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain | Q45866495 | ||
A modified Sindbis vector for prolonged gene expression in neurons | Q73644371 | ||
Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus | Q24523073 | ||
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy | Q24535690 | ||
Next-generation optical technologies for illuminating genetically targeted brain circuits | Q24649053 | ||
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors | Q24682739 | ||
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis | Q24684374 | ||
Diverse modes of axon elaboration in the developing neocortex | Q24814651 | ||
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis | Q28213353 | ||
A custom-made two-photon microscope and deconvolution system | Q30654643 | ||
Axons and synaptic boutons are highly dynamic in adult visual cortex | Q33236808 | ||
Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. | Q33781976 | ||
Clades of Adeno-associated viruses are widely disseminated in human tissues. | Q34193756 | ||
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo | Q34277742 | ||
Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats | Q34436780 | ||
Selective and rapid uptake of adeno-associated virus type 2 in brain | Q34471578 | ||
Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS | Q34472181 | ||
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
Recombinant AAV-mediated gene delivery to the central nervous system. | Q35673387 | ||
Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction | Q35928797 | ||
Adeno-associated virus (AAV) vectors in the CNS. | Q36173003 | ||
dsAAV type 2-mediated gene transfer of MORS196A-EGFP into spinal cord as a pain management paradigm | Q36289075 | ||
Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. | Q36541150 | ||
Gene therapy vectors based on adeno-associated virus type 1. | Q39550492 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 10 | |
P1104 | number of pages | 15 | |
P304 | page(s) | 674-688 | |
P577 | publication date | 2009-09-01 | |
P1433 | published in | Developmental Neurobiology | Q15716734 |
P1476 | title | Rapid, long-term labeling of cells in the developing and adult rodent visual cortex using double-stranded adeno-associated viral vectors | |
P478 | volume | 69 |